APA

McGillivray S. M., Tran D. N., Ramadoss N. S., Alumasa J. N., Okumura C. Y., Sakoulas G., Vaughn M. M., Zhang D. X., Keiler K. C. & Nizet V. (20120628). Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. : Antimicrobial agents and chemotherapy.

Chicago

McGillivray Shauna M, Tran Dan N, Ramadoss Nitya S, Alumasa John N, Okumura Cheryl Y, Sakoulas George, Vaughn Micah M, Zhang Dawn X, Keiler Kenneth C and Nizet Victor. 20120628. Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. : Antimicrobial agents and chemotherapy.

Harvard

McGillivray S. M., Tran D. N., Ramadoss N. S., Alumasa J. N., Okumura C. Y., Sakoulas G., Vaughn M. M., Zhang D. X., Keiler K. C. and Nizet V. (20120628). Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. : Antimicrobial agents and chemotherapy.

MLA

McGillivray Shauna M, Tran Dan N, Ramadoss Nitya S, Alumasa John N, Okumura Cheryl Y, Sakoulas George, Vaughn Micah M, Zhang Dawn X, Keiler Kenneth C and Nizet Victor. Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. : Antimicrobial agents and chemotherapy. 20120628.